Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Effects of amiodarone on thyroid function]

P Caron1

  • 1Service d'Endocrinologie, CHU Rangueil, Toulouse.

Presse Medicale (Paris, France : 1983)
|December 2, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers. Clin Pharmacol Ther 81 392-400, 2007.

Clinical journal of the American Society of Nephrology : CJASN·2023
Same author

Graves' orbitopathy post-SARS-CoV-2 vaccines: report on six patients.

Journal of endocrinological investigation·2022
Same author

Research and innovation as a catalyst for food system transformation.

Trends in food science & technology·2020
Same author

Outcomes of orbital decompression using surgical navigation in thyroid-associated ophthalmopathy.

International journal of oral and maxillofacial surgery·2020
Same author

[Immune-related adverse events after immune checkpoints inhibitors in 2019: An update].

La Revue de medecine interne·2019
Same author

[Toxicity of immune checkpoints inhibitors].

Revue des maladies respiratoires·2018
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Amiodarone can cause thyroid dysfunction. Early thyroid screening and regular monitoring of thyroid function (TSH) during and after amiodarone treatment can significantly reduce the risks of amiodarone-induced hyperthyroidism.

Area of Science:

  • Cardiology and Endocrinology
  • Pharmacology and Toxicology

Context:

  • Amiodarone is a widely used anti-arrhythmic and anti-angina medication with a long history in cardiovascular medicine.
  • Thyroid dysfunction, including hyperthyroidism, has been a known complication of long-term amiodarone therapy since the 1970s.
  • Recent advancements have elucidated the pathogenic mechanisms of amiodarone-induced dysthyroidism, improving management strategies.

Purpose:

  • To describe the pathogenic mechanisms of amiodarone-induced dysthyroidism.
  • To propose a clinical approach for managing thyroid function in patients receiving amiodarone.
  • To emphasize the importance of pre-treatment screening and ongoing surveillance of thyroid function.

Summary:

  • Pre-prescription thyroid evaluation, including clinical history and hormone assays (TSH, free T4), is crucial to identify latent thyroid dysfunction.

Related Experiment Videos

  • Post-prescription monitoring involves regular clinical surveillance and TSH measurements at 3 months, then every 6 months.
  • Continued thyroid function monitoring is recommended at 6 and 12 months after amiodarone withdrawal.

    • Impact:

    • Improved understanding of amiodarone's effects on the thyroid has led to reduced severity of induced hyperthyroidism.
    • Implementation of proposed surveillance protocols can enhance patient safety and optimize cardiovascular treatment outcomes.
    • Early detection and management of thyroid dysfunction prevent potential complications and improve quality of life for patients on amiodarone.